Title of article
Long-term effects of darusentan on left-ventricular remodelling and clinical outcomes in the EndothelinA Receptor Antagonist Trial in Heart Failure (EARTH): randomised, double-blind, placebo-controlled trial
Author/Authors
Prof Inder Anand، نويسنده , , Prof John McMurray، نويسنده , , Prof Jay N Cohn، نويسنده , , Prof Marvin A Konstam، نويسنده , , Thomas Notter، نويسنده , , Kurt Quitzau، نويسنده , , Frank Ruschitzka، نويسنده , , Prof Thomas F Luscher، نويسنده ,
Issue Information
روزنامه با شماره پیاپی سال 2004
Pages
8
From page
347
To page
354
Abstract
Background Endothelin-receptor blockade provides haemodynamic benefit in experimental and clinical heart failure. We aimed to measure the effects of long-term endothelin-blockade on left-ventricular (LV) remodelling and clinical outcomes in patients with
Journal title
The Lancet
Serial Year
2004
Journal title
The Lancet
Record number
586729
Link To Document